| Bruchs membrane dystrophies | Ayşe ÖNER | 249–256 |
| Refrakter diabetik maküler ödem tedavisinde intravitreal ranibizumab enjeksiyonu | Sabiha Güngör KOBAT,BURAK TURGUT,Ülkü ÇELİKER,TAMER DEMİR | 257–261 |
| Multipl skleroz hastalarında optik koherans tomografi ile ganglion hücre kompleksi kalınlığının değerlendirilmesi | İbrahim Bülent BUTTANRI,Mehmet GENCER,Şahin SEVİM,İsmail DELİPOYRAZ,Didem SERİN,Bahtinur BUTTANRI,Recai TÜRKOĞLU | 262–266 |
| The Outcome of ıntravitreal anti-vegf in the treatment of choroidal neovascularization secondary to exudative agerelated macular degeneration in real life | Sibel DOĞUİZİ,Şengül ÖZDEK,Gökhan GÜRELİK,Berati HASANREİSOĞLU,Zeynep AKTAŞ,CELAL MURAT HASANREİSOĞLU | 267–272 |
| Evaluation of retrobulber flow parameters in non proliferatif diabetic retinopathy with color doppler ultrasonography | Mehmet Ragıp EKMEN,Yakup YEŞİLKAYA,Ayşe Gül ALTINTAŞ KOÇAK | 273–278 |
| The efficacy of intravitreal ranibizumab treatment in diffuse diabetic macular edema | EBRU ESEN,SELÇUK SIZMAZ,Göksu Hande ŞİMDİVAR,Elif ERDEM,Kemal YAR,Nihal DEMİRCAN | 279–282 |
| Prognostic significance of optical coherence tomographic findings in retinal vein occlusions | MAHMUT KAYA,Ömer TAKEŞ,ARİF TAYLAN ÖZTÜRK,Ferit Hakan ÖNER | 283–288 |
| Pars plana vitrectomy in refractory nontractional diabetic retinopathy | İbrahim KOÇAK,Ali AYDIN,Hacı KOÇ,Faruk KAYA | 289–292 |
| Systemic endothelial function in patients with nonproliferative diabetic retinopathy and proliferative diabetic retinopathy | Mustafa ATAŞ,Hasan Basri ARİFOĞLU,Bahadır ŞARLI,Süleyman DEMİRCAN,Ayşe ÖZKÖSE,Emine PANGAL,İsa YUVACI,Altan GÖKTAŞ | 293–296 |
| The results of vfq-25 and gazi vfq-10 after single dose of ıntravitreal anti-vegf treatment | Burçin YILDIZ KEPEZ,Nuriye Gökçen YALÇIN,Şengül ÖZDEK,Berati HASANREİSOĞLU | 297–301 |
| Meme kanserinin sistemik tutulumun ilk bulgusu olarak ortaya çıkan koroidal mikrometastaz | İBRAHİM TOPRAK | 302–304 |
|